Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ABBONews Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::102177005.png) ABBO News [@ABBONews](/creator/twitter/ABBONews) on x 14K followers
Created: 2025-07-07 11:24:39 UTC

🚨Share Spike: Apogee Therapeutics $APGE jumps XX% to $XX pre-market after the company posts positive 16-week Phase X APEX results for APG777, its anti-IL-13 antibody targeting moderate-to-severe atopic dermatitis.

![](https://pbs.twimg.com/media/GvQFHecXoAAawaz.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942182974755086346/c:line.svg)

**Related Topics**
[$apge](/topic/$apge)

[Post Link](https://x.com/ABBONews/status/1942182974755086346)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

ABBONews Avatar ABBO News @ABBONews on x 14K followers Created: 2025-07-07 11:24:39 UTC

🚨Share Spike: Apogee Therapeutics $APGE jumps XX% to $XX pre-market after the company posts positive 16-week Phase X APEX results for APG777, its anti-IL-13 antibody targeting moderate-to-severe atopic dermatitis.

XXX engagements

Engagements Line Chart

Related Topics $apge

Post Link

post/tweet::1942182974755086346
/post/tweet::1942182974755086346